Christopher Voigt of the Massachusetts Institute of Technology in the U.S., along with collaborators Michael Fischbach of the University of California San Francisco and Justin Sonnenburg of Stanford, will engineer a strain of a common bacterial inhabitant of the human gut to contain genetic sensors that can report biomarkers for intestinal disorders in a stool sample.